Back to Journals » Vascular Health and Risk Management » Volume 8

Erythrocyte sedimentation rate as a marker for coronary heart disease

Authors Yayan J

Received 17 December 2011

Accepted for publication 8 February 2012

Published 11 April 2012 Volume 2012:8 Pages 219—223

DOI https://doi.org/10.2147/VHRM.S29284

Review by Single-blind

Peer reviewer comments 3

Josef Yayan
Department of Internal Medicine, Vinzentius Hospital, Landau, Germany

Background: Patients with angina pectoris or myocardial infarction frequently present without evidence of cardiac-specific heart enzymes by laboratory analysis or specific pathologic electrocardiogram findings. The current study analyzed the efficacy of the erythrocyte sedimentation rate as an additional potential indicator for coronary heart disease, the aim being to enable quicker identification of patients with angina pectoris or myocardial infarction so that they can be more rapidly treated.
Methods: Patients with angina pectoris or myocardial infarction who had undergone a heart catheter examination were included in the study. The diagnosis of acute coronary heart disease was made by the physician who performed coronary angiography. Patients without coronary heart disease were used as a control group. The erythrocyte sedimentation rate was measured in all patients. Patients with angina pectoris or myocardial infarction and an inflammatory or tumor disease were excluded.
Results: The erythrocyte sedimentation rate was prolonged in 79 (58.09%) of 136 patients; 69 (50.74%) patients (95% confidence interval ±8.4%, 42.34%–59.14%) had coronary heart disease and a prolonged erythrocyte sedimentation rate. The erythrocyte sedimentation rate was prolonged in ten (7.35%) patients (95% confidence interval ±4.39%, 2.96%–11.74%) without coronary heart disease by coronary angiography. The specificity of the erythrocyte sedimentation rate for coronary heart disease was 70.59% and the sensitivity was 67.65%.
Conclusion: Erythrocyte sedimentation rate may be a useful additional diagnostic criterion for coronary heart disease.

Keywords: erythrocyte sedimentation rate, coronary heart disease, myocardial infarction, coronary angiography

A Letter to the Editor has been received and published for this article.

Creative Commons License This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.

Download Article [PDF]  View Full Text [HTML][Machine readable]

 

Other articles by this author:

Trends in intensive care in patients over 90 years of age

Yayan J

Clinical Interventions in Aging 2012, 7:339-347

Published Date: 6 September 2012

Effects of alteplase in the treatment of acute ischemic stroke

Yayan J

International Journal of General Medicine 2012, 5:743-751

Published Date: 6 September 2012

Myocardial infarction in patients over 90 years of age

Yayan J

Clinical Interventions in Aging 2012, 7:77-81

Published Date: 28 February 2012

Readers of this article also read:

Comparative efficacy and safety of local and systemic methotrexate injection in cesarean scar pregnancy

Peng P, Gui T, Liu X, Chen W, Liu Z

Therapeutics and Clinical Risk Management 2015, 11:137-142

Published Date: 27 January 2015

New drugs to treat multidrug-resistant tuberculosis: the case for bedaquiline

Leibert E, Danckers M, Rom WN

Therapeutics and Clinical Risk Management 2014, 10:597-602

Published Date: 29 July 2014

Is increasing the dose of Entecavir effective in partial virological responders?

Erturk A, Adnan Akdogan R, Parlak E, Cure E, Cumhur Cure M, Ozturk C

Drug Design, Development and Therapy 2014, 8:621-625

Published Date: 29 May 2014

Treatment of acute otitis externa with ciprofloxacin otic 0.2% antibiotic ear solution

Mösges R, Nematian-Samani M, Eichel A

Therapeutics and Clinical Risk Management 2011, 7:325-326

Published Date: 27 July 2011